Clinical Trials Directory

Trials / Completed

CompletedNCT06226298

Benefits of the Xiaxi Postural Hammock and a Xiaxi Exercise Program

Benefits of the Xiaxi Postural Hammock and a Xiaxi Exercise Program: A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
52 (actual)
Sponsor
Universidad Rey Juan Carlos · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Chronic low back pain is one of the main causes of pain, dysfunction and disability worldwide. In Spain, 93% of the population has had back pain in the last year, and it is estimated that 50% of sick leave is due to this cause. This entails a great socioeconomic burden, since it is the main cause of absenteeism from work and the excessive use of therapeutic services. Musculoskeletal disorders are related and associated with psychologically stressful jobs, that is, with psychosocial factors at work and related work stressors, such as time pressure, low job control, poor social or supervisor support, effort-reward imbalance or work-life conflict. Clinical management of both situations encompasses a variety of approaches, including medication and early physical exercise, which have shown promise in reducing pain and improving function. A novel approach to address these problems is the use of Xiaxi, a patented postural hammock with multiple angles of inclination that promotes relaxation and elongation of the posterior chain, thereby improving overall well-being. Combining the use of Xiaxi with a comprehensive program of strengthening, stretching and relaxation exercises could offer benefits in the prevention and reduction of back pain.

Conditions

Interventions

TypeNameDescription
DEVICEXiaxi postural hammockLie in the Xiaxi postural hammock for 10 minutes for 5 days.
BEHAVIORALYoga matLie in the Yoga mat for 10 minutes for 5 days.

Timeline

Start date
2023-11-13
Primary completion
2023-11-20
Completion
2023-12-01
First posted
2024-01-26
Last updated
2024-01-26

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06226298. Inclusion in this directory is not an endorsement.